Global Artificial Intelligence in Pharma and Biotech Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Artificial Intelligence in Pharma and Biotech market size was valued at US$ 2192 million in 2025 and is forecast to a readjusted size of US$ 17923 million by 2032 with a CAGR of 30.3% during review period.
Artificial Intelligence in Pharma and Biotech refers to the application of artificial intelligence technologies in pharmaceutical, biotechnology, and life science research and commercialization processes. By utilizing technologies such as machine learning, deep learning, natural language processing (NLP), generative AI, computer vision, and knowledge graphs, AI systems analyze and process biomedical data, clinical information, molecular structures, and scientific literature to improve drug discovery efficiency, optimize clinical development, accelerate research and development processes, and reduce development costs. Key applications of AI in pharmaceutical and biotechnology industries include AI-driven drug discovery, target identification and validation, molecular design and optimization, protein structure prediction, clinical trial design and patient recruitment optimization, biomarker discovery, scientific literature analysis, and pharmaceutical manufacturing quality control. AI enables pharmaceutical and biotechnology companies to shorten drug development timelines, improve the accuracy of candidate drug screening, and accelerate advances in precision medicine, personalized therapies, and next-generation biopharmaceutical development.
Global Artificial Intelligence in Pharma and Biotech market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Pharma and Biotech market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Pharma and Biotech market shares of main players, in revenue ($ Million), 2021-2026
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Artificial Intelligence in Pharma and Biotech market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Chapter 2, to profile the top players of Artificial Intelligence in Pharma and Biotech, with revenue, gross margin, and global market share of Artificial Intelligence in Pharma and Biotech from 2021 to 2026.
Chapter 3, the Artificial Intelligence in Pharma and Biotech competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence in Pharma and Biotech market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Pharma and Biotech.
Chapter 13, to describe Artificial Intelligence in Pharma and Biotech research findings and conclusion.
Artificial Intelligence in Pharma and Biotech refers to the application of artificial intelligence technologies in pharmaceutical, biotechnology, and life science research and commercialization processes. By utilizing technologies such as machine learning, deep learning, natural language processing (NLP), generative AI, computer vision, and knowledge graphs, AI systems analyze and process biomedical data, clinical information, molecular structures, and scientific literature to improve drug discovery efficiency, optimize clinical development, accelerate research and development processes, and reduce development costs. Key applications of AI in pharmaceutical and biotechnology industries include AI-driven drug discovery, target identification and validation, molecular design and optimization, protein structure prediction, clinical trial design and patient recruitment optimization, biomarker discovery, scientific literature analysis, and pharmaceutical manufacturing quality control. AI enables pharmaceutical and biotechnology companies to shorten drug development timelines, improve the accuracy of candidate drug screening, and accelerate advances in precision medicine, personalized therapies, and next-generation biopharmaceutical development.
Report Scope
This report is a detailed and comprehensive analysis for global Artificial Intelligence in Pharma and Biotech market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.Key Features:
Global Artificial Intelligence in Pharma and Biotech market size and forecasts, in consumption value ($ Million), 2021-2032Global Artificial Intelligence in Pharma and Biotech market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Pharma and Biotech market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Artificial Intelligence in Pharma and Biotech market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Artificial Intelligence in Pharma and Biotech
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Artificial Intelligence in Pharma and Biotech market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Market segment by Type
- AI Drug Discovery
- Preclinical Research AI
- Clinical Trial AI
- Others
Market segment by Technology
- Machine Learning
- Deep Learning
- Generative AI
- Computer Vision
- Others
Market segment by Application
- Oncology
- Neurology
- Immunology
- Rare Diseases
- Infectious Diseases
- Others
Market segment by players, this report covers
- AstraZeneca
- Thales Group
- IBM Corp.
- ForeSee Medical
- Atomwise
- Cloud Pharmaceuticals
- GNS Healthcare
- Microsoft Corporation
- Novartis AG
- NVIDIA Corporation
- Pfizer
- Recursion Pharmaceuticals
- XtalPi Inc
- Aidoc
- AliveCor
- GE Healthcare
- Imagen Technologies
- Vuno Inc.
- IDx Technologies Inc.
- Siemens Healthcare GmbH
- Neural Analytics
- Insilico Medicine
Market segment by regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
- South America (Brazil, Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter Outline
Chapter 1, to describe Artificial Intelligence in Pharma and Biotech product scope, market overview, market estimation caveats and base year.Chapter 2, to profile the top players of Artificial Intelligence in Pharma and Biotech, with revenue, gross margin, and global market share of Artificial Intelligence in Pharma and Biotech from 2021 to 2026.
Chapter 3, the Artificial Intelligence in Pharma and Biotech competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Artificial Intelligence in Pharma and Biotech market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Artificial Intelligence in Pharma and Biotech.
Chapter 13, to describe Artificial Intelligence in Pharma and Biotech research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence in Pharma and Biotech by Type
1.3.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type in 2025
1.3.3 AI Drug Discovery
1.3.4 Preclinical Research AI
1.3.5 Clinical Trial AI
1.3.6 Others
1.4 Classification of Artificial Intelligence in Pharma and Biotech by Technology
1.4.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Technology in 2025
1.4.3 Machine Learning
1.4.4 Deep Learning
1.4.5 Generative AI
1.4.6 Computer Vision
1.4.7 Others
1.5 Global Artificial Intelligence in Pharma and Biotech Market by Application
1.5.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Oncology
1.5.3 Neurology
1.5.4 Immunology
1.5.5 Rare Diseases
1.5.6 Infectious Diseases
1.5.7 Others
1.6 Global Artificial Intelligence in Pharma and Biotech Market Size & Forecast
1.7 Global Artificial Intelligence in Pharma and Biotech Market Size and Forecast by Region
1.7.1 Global Artificial Intelligence in Pharma and Biotech Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Artificial Intelligence in Pharma and Biotech Market Size by Region, (2021-2032)
1.7.3 North America Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.4 Europe Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.6 South America Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Solutions
2.1.4 AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Thales Group
2.2.1 Thales Group Details
2.2.2 Thales Group Major Business
2.2.3 Thales Group Artificial Intelligence in Pharma and Biotech Product and Solutions
2.2.4 Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thales Group Recent Developments and Future Plans
2.3 IBM Corp.
2.3.1 IBM Corp. Details
2.3.2 IBM Corp. Major Business
2.3.3 IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.3.4 IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 IBM Corp. Recent Developments and Future Plans
2.4 ForeSee Medical
2.4.1 ForeSee Medical Details
2.4.2 ForeSee Medical Major Business
2.4.3 ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Solutions
2.4.4 ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ForeSee Medical Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence in Pharma and Biotech Product and Solutions
2.5.4 Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Cloud Pharmaceuticals
2.6.1 Cloud Pharmaceuticals Details
2.6.2 Cloud Pharmaceuticals Major Business
2.6.3 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
2.6.4 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.7 GNS Healthcare
2.7.1 GNS Healthcare Details
2.7.2 GNS Healthcare Major Business
2.7.3 GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
2.7.4 GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GNS Healthcare Recent Developments and Future Plans
2.8 Microsoft Corporation
2.8.1 Microsoft Corporation Details
2.8.2 Microsoft Corporation Major Business
2.8.3 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
2.8.4 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Microsoft Corporation Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Artificial Intelligence in Pharma and Biotech Product and Solutions
2.9.4 Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 NVIDIA Corporation
2.10.1 NVIDIA Corporation Details
2.10.2 NVIDIA Corporation Major Business
2.10.3 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
2.10.4 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 NVIDIA Corporation Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Artificial Intelligence in Pharma and Biotech Product and Solutions
2.11.4 Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Pfizer Recent Developments and Future Plans
2.12 Recursion Pharmaceuticals
2.12.1 Recursion Pharmaceuticals Details
2.12.2 Recursion Pharmaceuticals Major Business
2.12.3 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
2.12.4 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.13 XtalPi Inc
2.13.1 XtalPi Inc Details
2.13.2 XtalPi Inc Major Business
2.13.3 XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Solutions
2.13.4 XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 XtalPi Inc Recent Developments and Future Plans
2.14 Aidoc
2.14.1 Aidoc Details
2.14.2 Aidoc Major Business
2.14.3 Aidoc Artificial Intelligence in Pharma and Biotech Product and Solutions
2.14.4 Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Aidoc Recent Developments and Future Plans
2.15 AliveCor
2.15.1 AliveCor Details
2.15.2 AliveCor Major Business
2.15.3 AliveCor Artificial Intelligence in Pharma and Biotech Product and Solutions
2.15.4 AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 AliveCor Recent Developments and Future Plans
2.16 GE Healthcare
2.16.1 GE Healthcare Details
2.16.2 GE Healthcare Major Business
2.16.3 GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
2.16.4 GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 GE Healthcare Recent Developments and Future Plans
2.17 Imagen Technologies
2.17.1 Imagen Technologies Details
2.17.2 Imagen Technologies Major Business
2.17.3 Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Solutions
2.17.4 Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Imagen Technologies Recent Developments and Future Plans
2.18 Vuno Inc.
2.18.1 Vuno Inc. Details
2.18.2 Vuno Inc. Major Business
2.18.3 Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.18.4 Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Vuno Inc. Recent Developments and Future Plans
2.19 IDx Technologies Inc.
2.19.1 IDx Technologies Inc. Details
2.19.2 IDx Technologies Inc. Major Business
2.19.3 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.19.4 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 IDx Technologies Inc. Recent Developments and Future Plans
2.20 Siemens Healthcare GmbH
2.20.1 Siemens Healthcare GmbH Details
2.20.2 Siemens Healthcare GmbH Major Business
2.20.3 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Solutions
2.20.4 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Siemens Healthcare GmbH Recent Developments and Future Plans
2.21 Neural Analytics
2.21.1 Neural Analytics Details
2.21.2 Neural Analytics Major Business
2.21.3 Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Solutions
2.21.4 Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Neural Analytics Recent Developments and Future Plans
2.22 Insilico Medicine
2.22.1 Insilico Medicine Details
2.22.2 Insilico Medicine Major Business
2.22.3 Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Solutions
2.22.4 Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Insilico Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence in Pharma and Biotech Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence in Pharma and Biotech by Company Revenue
3.2.2 Top 3 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
3.3 Artificial Intelligence in Pharma and Biotech Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence in Pharma and Biotech Market: Region Footprint
3.3.2 Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
3.3.3 Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence in Pharma and Biotech Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence in Pharma and Biotech Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence in Pharma and Biotech Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence in Pharma and Biotech Market Size by Country
6.3.1 North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence in Pharma and Biotech Market Size by Country
7.3.1 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence in Pharma and Biotech Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence in Pharma and Biotech Market Size by Country
9.3.1 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence in Pharma and Biotech Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence in Pharma and Biotech Market Drivers
11.2 Artificial Intelligence in Pharma and Biotech Market Restraints
11.3 Artificial Intelligence in Pharma and Biotech Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence in Pharma and Biotech Industry Chain
12.2 Artificial Intelligence in Pharma and Biotech Upstream Analysis
12.3 Artificial Intelligence in Pharma and Biotech Midstream Analysis
12.4 Artificial Intelligence in Pharma and Biotech Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Artificial Intelligence in Pharma and Biotech by Type
1.3.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type in 2025
1.3.3 AI Drug Discovery
1.3.4 Preclinical Research AI
1.3.5 Clinical Trial AI
1.3.6 Others
1.4 Classification of Artificial Intelligence in Pharma and Biotech by Technology
1.4.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Technology: 2021 Versus 2025 Versus 2032
1.4.2 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Technology in 2025
1.4.3 Machine Learning
1.4.4 Deep Learning
1.4.5 Generative AI
1.4.6 Computer Vision
1.4.7 Others
1.5 Global Artificial Intelligence in Pharma and Biotech Market by Application
1.5.1 Overview: Global Artificial Intelligence in Pharma and Biotech Market Size by Application: 2021 Versus 2025 Versus 2032
1.5.2 Oncology
1.5.3 Neurology
1.5.4 Immunology
1.5.5 Rare Diseases
1.5.6 Infectious Diseases
1.5.7 Others
1.6 Global Artificial Intelligence in Pharma and Biotech Market Size & Forecast
1.7 Global Artificial Intelligence in Pharma and Biotech Market Size and Forecast by Region
1.7.1 Global Artificial Intelligence in Pharma and Biotech Market Size by Region: 2021 VS 2025 VS 2032
1.7.2 Global Artificial Intelligence in Pharma and Biotech Market Size by Region, (2021-2032)
1.7.3 North America Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.4 Europe Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.5 Asia-Pacific Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.6 South America Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
1.7.7 Middle East & Africa Artificial Intelligence in Pharma and Biotech Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Solutions
2.1.4 AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 AstraZeneca Recent Developments and Future Plans
2.2 Thales Group
2.2.1 Thales Group Details
2.2.2 Thales Group Major Business
2.2.3 Thales Group Artificial Intelligence in Pharma and Biotech Product and Solutions
2.2.4 Thales Group Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Thales Group Recent Developments and Future Plans
2.3 IBM Corp.
2.3.1 IBM Corp. Details
2.3.2 IBM Corp. Major Business
2.3.3 IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.3.4 IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 IBM Corp. Recent Developments and Future Plans
2.4 ForeSee Medical
2.4.1 ForeSee Medical Details
2.4.2 ForeSee Medical Major Business
2.4.3 ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Solutions
2.4.4 ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 ForeSee Medical Recent Developments and Future Plans
2.5 Atomwise
2.5.1 Atomwise Details
2.5.2 Atomwise Major Business
2.5.3 Atomwise Artificial Intelligence in Pharma and Biotech Product and Solutions
2.5.4 Atomwise Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Atomwise Recent Developments and Future Plans
2.6 Cloud Pharmaceuticals
2.6.1 Cloud Pharmaceuticals Details
2.6.2 Cloud Pharmaceuticals Major Business
2.6.3 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
2.6.4 Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.7 GNS Healthcare
2.7.1 GNS Healthcare Details
2.7.2 GNS Healthcare Major Business
2.7.3 GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
2.7.4 GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 GNS Healthcare Recent Developments and Future Plans
2.8 Microsoft Corporation
2.8.1 Microsoft Corporation Details
2.8.2 Microsoft Corporation Major Business
2.8.3 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
2.8.4 Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Microsoft Corporation Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Artificial Intelligence in Pharma and Biotech Product and Solutions
2.9.4 Novartis AG Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 NVIDIA Corporation
2.10.1 NVIDIA Corporation Details
2.10.2 NVIDIA Corporation Major Business
2.10.3 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
2.10.4 NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 NVIDIA Corporation Recent Developments and Future Plans
2.11 Pfizer
2.11.1 Pfizer Details
2.11.2 Pfizer Major Business
2.11.3 Pfizer Artificial Intelligence in Pharma and Biotech Product and Solutions
2.11.4 Pfizer Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Pfizer Recent Developments and Future Plans
2.12 Recursion Pharmaceuticals
2.12.1 Recursion Pharmaceuticals Details
2.12.2 Recursion Pharmaceuticals Major Business
2.12.3 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
2.12.4 Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Recursion Pharmaceuticals Recent Developments and Future Plans
2.13 XtalPi Inc
2.13.1 XtalPi Inc Details
2.13.2 XtalPi Inc Major Business
2.13.3 XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Solutions
2.13.4 XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 XtalPi Inc Recent Developments and Future Plans
2.14 Aidoc
2.14.1 Aidoc Details
2.14.2 Aidoc Major Business
2.14.3 Aidoc Artificial Intelligence in Pharma and Biotech Product and Solutions
2.14.4 Aidoc Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Aidoc Recent Developments and Future Plans
2.15 AliveCor
2.15.1 AliveCor Details
2.15.2 AliveCor Major Business
2.15.3 AliveCor Artificial Intelligence in Pharma and Biotech Product and Solutions
2.15.4 AliveCor Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 AliveCor Recent Developments and Future Plans
2.16 GE Healthcare
2.16.1 GE Healthcare Details
2.16.2 GE Healthcare Major Business
2.16.3 GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
2.16.4 GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 GE Healthcare Recent Developments and Future Plans
2.17 Imagen Technologies
2.17.1 Imagen Technologies Details
2.17.2 Imagen Technologies Major Business
2.17.3 Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Solutions
2.17.4 Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Imagen Technologies Recent Developments and Future Plans
2.18 Vuno Inc.
2.18.1 Vuno Inc. Details
2.18.2 Vuno Inc. Major Business
2.18.3 Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.18.4 Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 Vuno Inc. Recent Developments and Future Plans
2.19 IDx Technologies Inc.
2.19.1 IDx Technologies Inc. Details
2.19.2 IDx Technologies Inc. Major Business
2.19.3 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
2.19.4 IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 IDx Technologies Inc. Recent Developments and Future Plans
2.20 Siemens Healthcare GmbH
2.20.1 Siemens Healthcare GmbH Details
2.20.2 Siemens Healthcare GmbH Major Business
2.20.3 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Solutions
2.20.4 Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Siemens Healthcare GmbH Recent Developments and Future Plans
2.21 Neural Analytics
2.21.1 Neural Analytics Details
2.21.2 Neural Analytics Major Business
2.21.3 Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Solutions
2.21.4 Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Neural Analytics Recent Developments and Future Plans
2.22 Insilico Medicine
2.22.1 Insilico Medicine Details
2.22.2 Insilico Medicine Major Business
2.22.3 Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Solutions
2.22.4 Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 Insilico Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Artificial Intelligence in Pharma and Biotech Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Artificial Intelligence in Pharma and Biotech by Company Revenue
3.2.2 Top 3 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
3.2.3 Top 6 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
3.3 Artificial Intelligence in Pharma and Biotech Market: Overall Company Footprint Analysis
3.3.1 Artificial Intelligence in Pharma and Biotech Market: Region Footprint
3.3.2 Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
3.3.3 Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Artificial Intelligence in Pharma and Biotech Consumption Value and Market Share by Type (2021-2026)
4.2 Global Artificial Intelligence in Pharma and Biotech Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2026)
5.2 Global Artificial Intelligence in Pharma and Biotech Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
6.2 North America Artificial Intelligence in Pharma and Biotech Market Size by Application (2021-2032)
6.3 North America Artificial Intelligence in Pharma and Biotech Market Size by Country
6.3.1 North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
6.3.2 United States Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
6.3.3 Canada Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
6.3.4 Mexico Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
7.2 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
7.3 Europe Artificial Intelligence in Pharma and Biotech Market Size by Country
7.3.1 Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
7.3.2 Germany Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.3 France Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.5 Russia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
7.3.6 Italy Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Artificial Intelligence in Pharma and Biotech Market Size by Region
8.3.1 Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2032)
8.3.2 China Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.3 Japan Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.4 South Korea Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.5 India Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
8.3.7 Australia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
9.2 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
9.3 South America Artificial Intelligence in Pharma and Biotech Market Size by Country
9.3.1 South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
9.3.2 Brazil Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
9.3.3 Argentina Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Artificial Intelligence in Pharma and Biotech Market Size by Country
10.3.1 Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2032)
10.3.2 Turkey Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
10.3.4 UAE Artificial Intelligence in Pharma and Biotech Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Artificial Intelligence in Pharma and Biotech Market Drivers
11.2 Artificial Intelligence in Pharma and Biotech Market Restraints
11.3 Artificial Intelligence in Pharma and Biotech Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Artificial Intelligence in Pharma and Biotech Industry Chain
12.2 Artificial Intelligence in Pharma and Biotech Upstream Analysis
12.3 Artificial Intelligence in Pharma and Biotech Midstream Analysis
12.4 Artificial Intelligence in Pharma and Biotech Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2027-2032) & (USD Million)
Table 6. AstraZeneca Company Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 9. AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. AstraZeneca Recent Developments and Future Plans
Table 11. Thales Group Company Information, Head Office, and Major Competitors
Table 12. Thales Group Major Business
Table 13. Thales Group Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 14. Thales Group Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Thales Group Recent Developments and Future Plans
Table 16. IBM Corp. Company Information, Head Office, and Major Competitors
Table 17. IBM Corp. Major Business
Table 18. IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 19. IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. ForeSee Medical Company Information, Head Office, and Major Competitors
Table 21. ForeSee Medical Major Business
Table 22. ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 23. ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. ForeSee Medical Recent Developments and Future Plans
Table 25. Atomwise Company Information, Head Office, and Major Competitors
Table 26. Atomwise Major Business
Table 27. Atomwise Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 28. Atomwise Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Atomwise Recent Developments and Future Plans
Table 30. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Cloud Pharmaceuticals Major Business
Table 32. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 33. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 35. GNS Healthcare Company Information, Head Office, and Major Competitors
Table 36. GNS Healthcare Major Business
Table 37. GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 38. GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. GNS Healthcare Recent Developments and Future Plans
Table 40. Microsoft Corporation Company Information, Head Office, and Major Competitors
Table 41. Microsoft Corporation Major Business
Table 42. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 43. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Microsoft Corporation Recent Developments and Future Plans
Table 45. Novartis AG Company Information, Head Office, and Major Competitors
Table 46. Novartis AG Major Business
Table 47. Novartis AG Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 48. Novartis AG Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Novartis AG Recent Developments and Future Plans
Table 50. NVIDIA Corporation Company Information, Head Office, and Major Competitors
Table 51. NVIDIA Corporation Major Business
Table 52. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 53. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. NVIDIA Corporation Recent Developments and Future Plans
Table 55. Pfizer Company Information, Head Office, and Major Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 58. Pfizer Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Pfizer Recent Developments and Future Plans
Table 60. Recursion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Recursion Pharmaceuticals Major Business
Table 62. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 63. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Recursion Pharmaceuticals Recent Developments and Future Plans
Table 65. XtalPi Inc Company Information, Head Office, and Major Competitors
Table 66. XtalPi Inc Major Business
Table 67. XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 68. XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. XtalPi Inc Recent Developments and Future Plans
Table 70. Aidoc Company Information, Head Office, and Major Competitors
Table 71. Aidoc Major Business
Table 72. Aidoc Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 73. Aidoc Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Aidoc Recent Developments and Future Plans
Table 75. AliveCor Company Information, Head Office, and Major Competitors
Table 76. AliveCor Major Business
Table 77. AliveCor Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 78. AliveCor Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AliveCor Recent Developments and Future Plans
Table 80. GE Healthcare Company Information, Head Office, and Major Competitors
Table 81. GE Healthcare Major Business
Table 82. GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 83. GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. GE Healthcare Recent Developments and Future Plans
Table 85. Imagen Technologies Company Information, Head Office, and Major Competitors
Table 86. Imagen Technologies Major Business
Table 87. Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 88. Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Imagen Technologies Recent Developments and Future Plans
Table 90. Vuno Inc. Company Information, Head Office, and Major Competitors
Table 91. Vuno Inc. Major Business
Table 92. Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 93. Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Vuno Inc. Recent Developments and Future Plans
Table 95. IDx Technologies Inc. Company Information, Head Office, and Major Competitors
Table 96. IDx Technologies Inc. Major Business
Table 97. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 98. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. IDx Technologies Inc. Recent Developments and Future Plans
Table 100. Siemens Healthcare GmbH Company Information, Head Office, and Major Competitors
Table 101. Siemens Healthcare GmbH Major Business
Table 102. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 103. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Siemens Healthcare GmbH Recent Developments and Future Plans
Table 105. Neural Analytics Company Information, Head Office, and Major Competitors
Table 106. Neural Analytics Major Business
Table 107. Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 108. Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Neural Analytics Recent Developments and Future Plans
Table 110. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 111. Insilico Medicine Major Business
Table 112. Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 113. Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Insilico Medicine Recent Developments and Future Plans
Table 115. Global Artificial Intelligence in Pharma and Biotech Revenue (USD Million) by Players (2021-2026)
Table 116. Global Artificial Intelligence in Pharma and Biotech Revenue Share by Players (2021-2026)
Table 117. Breakdown of Artificial Intelligence in Pharma and Biotech by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Artificial Intelligence in Pharma and Biotech, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 119. Head Office of Key Artificial Intelligence in Pharma and Biotech Players
Table 120. Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
Table 121. Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
Table 122. Artificial Intelligence in Pharma and Biotech New Market Entrants and Barriers to Market Entry
Table 123. Artificial Intelligence in Pharma and Biotech Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Artificial Intelligence in Pharma and Biotech Consumption Value (USD Million) by Type (2021-2026)
Table 125. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Type (2021-2026)
Table 126. Global Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Type (2027-2032)
Table 127. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026)
Table 128. Global Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Application (2027-2032)
Table 129. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 130. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 131. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 132. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 133. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 134. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 136. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 137. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 138. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 139. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 140. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 142. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 143. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 144. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 145. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2027-2032) & (USD Million)
Table 147. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 148. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 149. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 150. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 151. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 154. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 155. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 156. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 157. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 158. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 159. Global Key Players of Artificial Intelligence in Pharma and Biotech Upstream (Raw Materials)
Table 160. Global Artificial Intelligence in Pharma and Biotech Typical Customers
Table 1. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Table 3. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 4. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 5. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2027-2032) & (USD Million)
Table 6. AstraZeneca Company Information, Head Office, and Major Competitors
Table 7. AstraZeneca Major Business
Table 8. AstraZeneca Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 9. AstraZeneca Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. AstraZeneca Recent Developments and Future Plans
Table 11. Thales Group Company Information, Head Office, and Major Competitors
Table 12. Thales Group Major Business
Table 13. Thales Group Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 14. Thales Group Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Thales Group Recent Developments and Future Plans
Table 16. IBM Corp. Company Information, Head Office, and Major Competitors
Table 17. IBM Corp. Major Business
Table 18. IBM Corp. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 19. IBM Corp. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. ForeSee Medical Company Information, Head Office, and Major Competitors
Table 21. ForeSee Medical Major Business
Table 22. ForeSee Medical Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 23. ForeSee Medical Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. ForeSee Medical Recent Developments and Future Plans
Table 25. Atomwise Company Information, Head Office, and Major Competitors
Table 26. Atomwise Major Business
Table 27. Atomwise Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 28. Atomwise Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Atomwise Recent Developments and Future Plans
Table 30. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 31. Cloud Pharmaceuticals Major Business
Table 32. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 33. Cloud Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 35. GNS Healthcare Company Information, Head Office, and Major Competitors
Table 36. GNS Healthcare Major Business
Table 37. GNS Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 38. GNS Healthcare Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. GNS Healthcare Recent Developments and Future Plans
Table 40. Microsoft Corporation Company Information, Head Office, and Major Competitors
Table 41. Microsoft Corporation Major Business
Table 42. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 43. Microsoft Corporation Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 44. Microsoft Corporation Recent Developments and Future Plans
Table 45. Novartis AG Company Information, Head Office, and Major Competitors
Table 46. Novartis AG Major Business
Table 47. Novartis AG Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 48. Novartis AG Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 49. Novartis AG Recent Developments and Future Plans
Table 50. NVIDIA Corporation Company Information, Head Office, and Major Competitors
Table 51. NVIDIA Corporation Major Business
Table 52. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 53. NVIDIA Corporation Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 54. NVIDIA Corporation Recent Developments and Future Plans
Table 55. Pfizer Company Information, Head Office, and Major Competitors
Table 56. Pfizer Major Business
Table 57. Pfizer Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 58. Pfizer Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 59. Pfizer Recent Developments and Future Plans
Table 60. Recursion Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 61. Recursion Pharmaceuticals Major Business
Table 62. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 63. Recursion Pharmaceuticals Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 64. Recursion Pharmaceuticals Recent Developments and Future Plans
Table 65. XtalPi Inc Company Information, Head Office, and Major Competitors
Table 66. XtalPi Inc Major Business
Table 67. XtalPi Inc Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 68. XtalPi Inc Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 69. XtalPi Inc Recent Developments and Future Plans
Table 70. Aidoc Company Information, Head Office, and Major Competitors
Table 71. Aidoc Major Business
Table 72. Aidoc Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 73. Aidoc Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 74. Aidoc Recent Developments and Future Plans
Table 75. AliveCor Company Information, Head Office, and Major Competitors
Table 76. AliveCor Major Business
Table 77. AliveCor Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 78. AliveCor Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 79. AliveCor Recent Developments and Future Plans
Table 80. GE Healthcare Company Information, Head Office, and Major Competitors
Table 81. GE Healthcare Major Business
Table 82. GE Healthcare Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 83. GE Healthcare Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 84. GE Healthcare Recent Developments and Future Plans
Table 85. Imagen Technologies Company Information, Head Office, and Major Competitors
Table 86. Imagen Technologies Major Business
Table 87. Imagen Technologies Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 88. Imagen Technologies Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 89. Imagen Technologies Recent Developments and Future Plans
Table 90. Vuno Inc. Company Information, Head Office, and Major Competitors
Table 91. Vuno Inc. Major Business
Table 92. Vuno Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 93. Vuno Inc. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 94. Vuno Inc. Recent Developments and Future Plans
Table 95. IDx Technologies Inc. Company Information, Head Office, and Major Competitors
Table 96. IDx Technologies Inc. Major Business
Table 97. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 98. IDx Technologies Inc. Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 99. IDx Technologies Inc. Recent Developments and Future Plans
Table 100. Siemens Healthcare GmbH Company Information, Head Office, and Major Competitors
Table 101. Siemens Healthcare GmbH Major Business
Table 102. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 103. Siemens Healthcare GmbH Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 104. Siemens Healthcare GmbH Recent Developments and Future Plans
Table 105. Neural Analytics Company Information, Head Office, and Major Competitors
Table 106. Neural Analytics Major Business
Table 107. Neural Analytics Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 108. Neural Analytics Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 109. Neural Analytics Recent Developments and Future Plans
Table 110. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 111. Insilico Medicine Major Business
Table 112. Insilico Medicine Artificial Intelligence in Pharma and Biotech Product and Solutions
Table 113. Insilico Medicine Artificial Intelligence in Pharma and Biotech Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 114. Insilico Medicine Recent Developments and Future Plans
Table 115. Global Artificial Intelligence in Pharma and Biotech Revenue (USD Million) by Players (2021-2026)
Table 116. Global Artificial Intelligence in Pharma and Biotech Revenue Share by Players (2021-2026)
Table 117. Breakdown of Artificial Intelligence in Pharma and Biotech by Company Type (Tier 1, Tier 2, and Tier 3)
Table 118. Market Position of Players in Artificial Intelligence in Pharma and Biotech, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 119. Head Office of Key Artificial Intelligence in Pharma and Biotech Players
Table 120. Artificial Intelligence in Pharma and Biotech Market: Company Product Type Footprint
Table 121. Artificial Intelligence in Pharma and Biotech Market: Company Product Application Footprint
Table 122. Artificial Intelligence in Pharma and Biotech New Market Entrants and Barriers to Market Entry
Table 123. Artificial Intelligence in Pharma and Biotech Mergers, Acquisition, Agreements, and Collaborations
Table 124. Global Artificial Intelligence in Pharma and Biotech Consumption Value (USD Million) by Type (2021-2026)
Table 125. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Type (2021-2026)
Table 126. Global Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Type (2027-2032)
Table 127. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026)
Table 128. Global Artificial Intelligence in Pharma and Biotech Consumption Value Forecast by Application (2027-2032)
Table 129. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 130. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 131. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 132. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 133. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 134. North America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 135. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 136. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 137. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 138. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 139. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 140. Europe Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 141. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 142. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 143. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 144. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 145. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2021-2026) & (USD Million)
Table 146. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value by Region (2027-2032) & (USD Million)
Table 147. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 148. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 149. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 150. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 151. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 152. South America Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 153. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2021-2026) & (USD Million)
Table 154. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Type (2027-2032) & (USD Million)
Table 155. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2021-2026) & (USD Million)
Table 156. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Application (2027-2032) & (USD Million)
Table 157. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2021-2026) & (USD Million)
Table 158. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value by Country (2027-2032) & (USD Million)
Table 159. Global Key Players of Artificial Intelligence in Pharma and Biotech Upstream (Raw Materials)
Table 160. Global Artificial Intelligence in Pharma and Biotech Typical Customers
LIST OF FIGURES
Figure 1. Artificial Intelligence in Pharma and Biotech Picture
Figure 2. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type in 2025
Figure 4. AI Drug Discovery
Figure 5. Preclinical Research AI
Figure 6. Clinical Trial AI
Figure 7. Others
Figure 8. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Technology in 2025
Figure 10. Machine Learning
Figure 11. Deep Learning
Figure 12. Generative AI
Figure 13. Computer Vision
Figure 14. Others
Figure 15. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application in 2025
Figure 17. Oncology Picture
Figure 18. Neurology Picture
Figure 19. Immunology Picture
Figure 20. Rare Diseases Picture
Figure 21. Infectious Diseases Picture
Figure 22. Others Picture
Figure 23. Global Artificial Intelligence in Pharma and Biotech Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Artificial Intelligence in Pharma and Biotech Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Artificial Intelligence in Pharma and Biotech Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region in 2025
Figure 28. North America Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Artificial Intelligence in Pharma and Biotech Revenue Share by Players in 2025
Figure 35. Artificial Intelligence in Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Artificial Intelligence in Pharma and Biotech by Player Revenue in 2025
Figure 37. Top 3 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
Figure 38. Top 6 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
Figure 39. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Type (2021-2026)
Figure 40. Global Artificial Intelligence in Pharma and Biotech Market Share Forecast by Type (2027-2032)
Figure 41. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Application (2021-2026)
Figure 42. Global Artificial Intelligence in Pharma and Biotech Market Share Forecast by Application (2027-2032)
Figure 43. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 53. France Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 60. China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 63. India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 77. Artificial Intelligence in Pharma and Biotech Market Drivers
Figure 78. Artificial Intelligence in Pharma and Biotech Market Restraints
Figure 79. Artificial Intelligence in Pharma and Biotech Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Artificial Intelligence in Pharma and Biotech Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Artificial Intelligence in Pharma and Biotech Picture
Figure 2. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type in 2025
Figure 4. AI Drug Discovery
Figure 5. Preclinical Research AI
Figure 6. Clinical Trial AI
Figure 7. Others
Figure 8. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Technology, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Technology in 2025
Figure 10. Machine Learning
Figure 11. Deep Learning
Figure 12. Generative AI
Figure 13. Computer Vision
Figure 14. Others
Figure 15. Global Artificial Intelligence in Pharma and Biotech Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 16. Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application in 2025
Figure 17. Oncology Picture
Figure 18. Neurology Picture
Figure 19. Immunology Picture
Figure 20. Rare Diseases Picture
Figure 21. Infectious Diseases Picture
Figure 22. Others Picture
Figure 23. Global Artificial Intelligence in Pharma and Biotech Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Artificial Intelligence in Pharma and Biotech Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Artificial Intelligence in Pharma and Biotech Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region in 2025
Figure 28. North America Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Artificial Intelligence in Pharma and Biotech Revenue Share by Players in 2025
Figure 35. Artificial Intelligence in Pharma and Biotech Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Artificial Intelligence in Pharma and Biotech by Player Revenue in 2025
Figure 37. Top 3 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
Figure 38. Top 6 Artificial Intelligence in Pharma and Biotech Players Market Share in 2025
Figure 39. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Type (2021-2026)
Figure 40. Global Artificial Intelligence in Pharma and Biotech Market Share Forecast by Type (2027-2032)
Figure 41. Global Artificial Intelligence in Pharma and Biotech Consumption Value Share by Application (2021-2026)
Figure 42. Global Artificial Intelligence in Pharma and Biotech Market Share Forecast by Application (2027-2032)
Figure 43. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 53. France Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Region (2021-2032)
Figure 60. China Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 63. India Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Artificial Intelligence in Pharma and Biotech Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Artificial Intelligence in Pharma and Biotech Consumption Value (2021-2032) & (USD Million)
Figure 77. Artificial Intelligence in Pharma and Biotech Market Drivers
Figure 78. Artificial Intelligence in Pharma and Biotech Market Restraints
Figure 79. Artificial Intelligence in Pharma and Biotech Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Artificial Intelligence in Pharma and Biotech Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
